Clinical Trial Update: Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing monthly LAPS-Exendin to placebo in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LAPS-Exendin

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED